Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Induction of virus-specific immunity by iscoms

A D Osterhaus1, G F Rimmelzwaan

  • 1Institute of Virology, Erasmus University Rotterdam, The Netherlands.

Developments in Biological Standardization
|April 29, 1998
PubMed
Summary

Immune stimulating complexes (iscoms) are novel vaccine adjuvants that enhance immune responses. They effectively induce long-lasting antibody and T cell responses, offering protection against viral infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics of Succinylated Serum Albumin in Wistar Rats and Cynomolgus Monkeys: Implications for Dosage Regimens in the Therapy of HIV Infection.

Drug delivery·2016
Same author

Persistent spiking fever in a child with acute myeloid leukemia and disseminated infection with enterovirus.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2014
Same author

The hanta hunting study: underdiagnosis of Puumala hantavirus infections in symptomatic non-travelling leptospirosis-suspected patients in the Netherlands, in 2010 and April to November 2011.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2014
Same author

Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2013
Same author

Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2012
Same author

Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2012

Area of Science:

  • Immunology
  • Vaccinology
  • Nanotechnology

Background:

  • Immune stimulating complexes (iscoms) are nanoscale, cage-like structures composed of Quil A glycosides, cholesterol, and phospholipids.
  • Antigens can be integrated into iscoms, forming potent vaccine formulations.

Purpose of the Study:

  • To provide an overview of iscoms as an adjuvant system in viral vaccine development.
  • To highlight the principles and effectiveness of iscoms in inducing protective immunity against viral diseases.

Main Methods:

  • Review of existing data on iscoms in viral systems.
  • Discussion of relevant examples illustrating iscom principles.

Main Results:

  • Iscoms act as potent adjuvants, inducing high, long-lasting systemic and local antibody and T cell responses, even with pre-existing antibodies.
  • Iscoms facilitate MHC class I restricted CD8+ CTL responses.
  • Incorporation of relevant antigens into iscoms generally leads to adequate protection against viral infections.

Conclusions:

  • Iscoms represent a promising adjuvant system for viral vaccines.
  • Their ability to induce both humoral and cellular immunity, including CTL responses, is key to their protective potential.
  • Iscoms offer a versatile platform for developing effective vaccines against viral pathogens.

Related Experiment Videos